Bg Medicine Stock Beta
| BGMDDelisted Stock | USD 0.0002 0.00 0.00% |
BG Medicine fundamentals help investors to digest information that contributes to BG Medicine's financial success or failures. It also enables traders to predict the movement of BGMD Pink Sheet. The fundamental analysis module provides a way to measure BG Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BG Medicine pink sheet.
BGMD |
BG Medicine Company Beta Analysis
BG Medicine's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current BG Medicine Beta | 83.44 |
Most of BG Medicine's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BG Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, BG Medicine has a Beta of 83. This is much higher than that of the Life Sciences Tools & Services sector and notably higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
BGMD Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BG Medicine's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BG Medicine could also be used in its relative valuation, which is a method of valuing BG Medicine by comparing valuation metrics of similar companies.BG Medicine is currently under evaluation in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BG Medicine will likely underperform.
BGMD Fundamentals
| Return On Equity | -9.03 | ||||
| Return On Asset | -0.76 | ||||
| Operating Margin | (2.86) % | ||||
| Current Valuation | 545.97 K | ||||
| Shares Outstanding | 11.37 M | ||||
| Number Of Shares Shorted | 630.05 K | ||||
| Price To Earning | (0.06) X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 1.57 M | ||||
| Gross Profit | 1.06 M | ||||
| EBITDA | (4.39 M) | ||||
| Net Income | (5.3 M) | ||||
| Cash And Equivalents | 1.52 M | ||||
| Cash Per Share | 0.14 X | ||||
| Debt To Equity | 5.31 % | ||||
| Current Ratio | 1.65 X | ||||
| Book Value Per Share | (0.17) X | ||||
| Cash Flow From Operations | (3.67 M) | ||||
| Short Ratio | 2.66 X | ||||
| Earnings Per Share | (0.72) X | ||||
| Target Price | 1.4 | ||||
| Beta | 83.44 | ||||
| Market Capitalization | 545.97 K | ||||
| Total Asset | 2.13 M | ||||
| Retained Earnings | (161.49 M) | ||||
| Working Capital | 771 K | ||||
| Current Asset | 1.95 M | ||||
| Current Liabilities | 1.18 M | ||||
| Net Asset | 2.13 M |
About BG Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BG Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BG Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BG Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in BGMD Pink Sheet
If you are still planning to invest in BG Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BG Medicine's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |